AzTrials
AzTrials

Mechanical Ventilation ComplicationCeRes-CMVNCT05363085

The Cerebral-Respiratory Interaction in Controlled Mechanically Ventilated Neurosurgical Patients. (The CeRes-CMV Study)

An observational study of Mechanical Ventilation Complication and Neurological Disorder, run by Uppsala University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The impact of mechanical ventilation on intracranial perfusion is still not completely clarified. It is often assumed that raising airway pressure will invariably elevate the intracranial pressure, but this is not always the case. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Mechanically ventilated neurosurgical patients
How many people
30 participants
Where
No sites listed yet
Study dates
May 2022to May 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Critically ill adult patients affected by acute brain injury (e.g., subarachnoid hemorrhage, subdural hemorrhage, epidural hemorrhage, traumatic brain injury, intracerebral hemorrhage) admitted to the NICU of Uppsala. Consecutive patients will be prospectively screened for eligibility according to inclusion criteria

Who may be able to join

  • Age >18 years;
  • MV expected for more than 72 hours;
  • Not pregnant;
  • Informed consent from patient or next of kin.

Who cannot join

  • Previously demonstrated paralysis of the diaphragm or know pathology of the phrenic nerve or neuromuscular disorder,
  • Chest tube,
  • Patients with clinical conditions that contraindicate the insertion of esophageal/gastric catheters (e.g., esophagus rupture, esophageal bleeding),
  • Pacemaker and/or implantable cardioverter defibrillator, these last being a contraindication for EIT.
  • Hemicraniectomy. In case of late hemicraniectomy (after patient inclusion), the patient will drop-out from the study.
  • Relative contraindication: in case of skull base fracture the patient can be included only if oesophageal/gastric and NAVA catheters can be inserted orally.

Trial locations and contacts

No sites are listed yet.

Mariangela Pellegrini, MD, PhD contact

+460186110000

mariangela.pellegrini@surgsci.uu.se

About this study

Official title: The Effects of Airway Closure, Expiratory Flow Limitation and of a Passive Chest Wall on the Onset of an Uncontrolled Expiration and on Intracranial Pressure. An Observational Clinical Study on Neurosurgical Patients. (The CeRes-CMV Study)

The impact of mechanical ventilation on intracranial perfusion is still not completely clarified. It is often assumed that raising airway pressure will invariably elevate the intracranial pressure, but this is not always the case.

The effects of airway pressure on intracranial pressure can depend on several factors, and among others, an uncontrolled expiration and consequent lung collapse may have an influence on cerebral perfusion.

Read more

This study will investigate the incidence and the consequences of an uncontrolled expiration and expiratory lung collapse in critically ill neurosurgical patients during controlled mechanical ventilation.

Electrical impedance tomography measurements , oesophagus and gastric pressure, electrical activity of the diaphragm and intracranial pressure will be acquired in a synchronised manner during controlled mechanical ventilation. Moreover, airway opening pressure, expiratory flow limitation and recruitment/inflation ratio will be determined during controlled mechanical ventilation, on a daily bases until the patient recover his/her own spontaneous breathing.

Being tested
Mechanically ventilated neurosurgical patients
Medical subject headings
Nervous System Diseases, Lung Injury

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mechanically ventilated neurosurgical patientsOther

    Observational study where respiratory variables and intracranial pressure will be measured during mechanical ventilation and during specific respiratory manoeuvres. No intervention is planned.

Study groups in NCT05363085
Study groupRoleWhat they receive
Mechanically ventilated neurosurgical patientsObservational study in mechanically ventilated neurosurgical patients
Receives: Other: Mechanically ventilated neurosurgical patients

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The incidence of lung collapse

    The incidence of an uncontrolled expiration and consequent expiratory lung collapse (determined by expiratory flow limitation, airway opening pressure and expiratory thoracic impedance) increased chest-wall elastance in neurosurgical patients.

    Measured: during the period of controlled mechanical ventilation, an average of 14 days

  2. Correlation between lung recruitability and intracerebral pressure

    The influence of lung recruitability (determined by recruitment/inflation ratio and changes of thoracic impedance) on intra cerebral pressure in neurosurgical patients.

    Measured: during the period of controlled mechanical ventilation, an average of 14 days

  3. Correlation between lung collapse and intracerebral pressure

    The correlation between an uncontrolled expiration (determined by expiratory flow limitation, airway opening and expiratory thoracic impedance), increased chest-wall elastance and intracranial pressure in neurosurgical patients.

    Measured: during the period of controlled mechanical ventilation, an average of 14 days

Secondary outcomes (4)
  1. Intensive care unit (ICU) and hospital length of stay (LOS);

    Correlation between lung collapse and LOS

    Measured: At ICU/hospital discharge, an average of 30 days

  2. Number of days of mechanical ventilation

    Correlation between lung collapse and days of mechanical ventilation

    Measured: At ICU discharge, an average of 20 days

  3. 90-days mortality from intensive care unit admission

    Correlation between lung collapse and 90-days mortality

    Measured: 90 days after hospital discharge

  4. 30-day and 90-days neurological and functional outcomes

    Correlation between lung collapse and 30-day and 90-days neurological and functional outcomes (Disability Rating Scale, clinical frailty score, Glasgow Outcome Scale)

    Measured: 90 days after hospital discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 May 2022
  2. Study startMay 2022 (estimated)
  3. Primary completionDec 2022 (estimated)
  4. Study completionMay 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05363085
Sponsor's protocol ID
CeRes-CMV
Acronym
CeRes-CMV
Status last verified
May 2022
First submitted
27 Apr 2022
Last updated
5 May 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Bencze R, Kawati R, Hanell A, Lewen A, Enblad P, Engquist H, Bjarnadottir KJ, Joensen O, Barrueta Tenhunen A, Freden F, Brochard L, Perchiazzi G, Pellegrini M. Intracranial response to positive end-expiratory pressure is influenced by lung recruitability and gas distribution during mechanical ventilation in acute brain injury patients: a proof-of-concept physiological study. Intensive Care Med Exp. 2025 Apr 14;13(1):43. doi: 10.1186/s40635-025-00750-y.

    PubMed 40229445

Questions about this trial

What is this clinical trial studying?

An observational study of Mechanical Ventilation Complication and Neurological Disorder, run by Uppsala University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 May 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mariangela Pellegrini, MD, PhD (+460186110000, mariangela.pellegrini@surgsci.uu.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The incidence of lung collapse (time frame: during the period of controlled mechanical ventilation, an average of 14 days). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05363085, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 May 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in